Bunker Hill: Fulfilling Debenture Interest Payment Obligations through Share Issuance – A Heartfelt Announcement

Unlocking the Potential of Bunker Hill Mining Corp. A Story of Growth and Innovation As the news of Bunker Hill Mining Corp.’s decision to issue shares of common stock to holders of convertible debentures spreads, it marks a significant milestone in the company’s journey towards success. This move reflects a strategic approach to managing its…

Read More

Unlocking the Future: Verses AI Inc. Launches LIFE Private Placement Offering of up to C$10,000,000

Verses AI Inc. Announces Non-Brokered Private Placement Vancouver, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) Verses AI Inc. (CBOE: VERS) (OTCQX:VRSSF) (“Verses” or the “Company”) has made a significant announcement regarding its plans to complete a non-brokered private placement. The Company intends to offer up to 12,500,000 units at a price of $0.80 per Unit…

Read More

Breaking News: Clover Leaf Capital Corp. Postpones Special Meeting for Proposed Business Merger

Miami, FL and Kansas City, KS – Clover Leaf Capital Corp. and Digital Ally, Inc. Announce Special Meeting Adjournment Miami, FL and Kansas City, KS, Sept. 20, 2024 (GLOBE NEWSWIRE) — Clover Leaf Capital Corp. (Nasdaq: CLOE) (“CLOE” or “Clover Leaf”), a publicly traded special purpose acquisition company, and Digital Ally, Inc. (Nasdaq: DGLY) (“Digital…

Read More

Breaking News: Brookfield Corporation Converts Series 40 Preferred Shares – What This Means for Investors

Brookfield Corporation Announcement Brookfield Corporation Retains Series 40 Shares Brookfield Corporation (NYSE: BN, TSX: BN) recently announced that after considering all election notices received by the deadline for the conversion of its Cumulative Class A Preference Shares, Series 40 into Series 41, there were only 29,920 Series 40 Shares tendered for conversion. This number falls…

Read More

Take Action Now: Protect Your Investment with Sage Therapeutics, Inc. – A Warning from Robbins Geller Rudman & Dowd LLP

Sage Therapeutics Faces Class Action Lawsuit Background In a recent announcement on September 20, 2024, Robbins Geller Rudman & Dowd LLP revealed that purchasers or acquirers of Sage Therapeutics, Inc. (NASDAQ: SAGE) securities throughout the Class Period between April 12, 2021 and July 23, 2024, have until October 28, 2024, to seek appointment as lead…

Read More